跳至主要内容
临床试验/ISRCTN36220396
ISRCTN36220396已完成4 期

Randomised, double-blind, placebo-controlled trial of azithromycin in lung transplantation

Katholieke Universiteit Leuven and University Hospitals Leuven (Belgium) - Lab of Pneumology, Lung Transplant Unit0 个研究点目标入组 80 人开始时间: 2009年12月17日最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Stable LTx recipients at discharge after transplantation
  • 2. Signed informed consent
  • 3. Adult of either sex (aged at least 18 years old at moment of transplantation)
  • 4. Able to take oral medication

排除标准

  • 1. Prolonged and/or complicated intensive care unit (ICU) course after lung transplantation
  • 2. Early (less than 30 days post-transplant) post-operative death
  • 3. Major suture problems (airway stenosis or stent)
  • 4. Retransplantation (lung)
  • 5. Previous transplantation (solid organ)
  • 6. Multi-organ transplantation (lung and other solid organ)

研究者

发起方
Katholieke Universiteit Leuven and University Hospitals Leuven (Belgium) - Lab of Pneumology, Lung Transplant Unit

相似试验

Azithromycin in bronchiolitis obliterans syndrome | 临床试验